OGI

MKT CAP:$197M

Organigram Global Inc.

Market Cap

$197M

Healthcare·Drug Manufacturers - Specialty & Generic·🇨🇦 Canada·NASDAQ

Healthcare·Drug·🇨🇦·NASDAQ

Stock Price

$1.59-$0.14 (-8.09%)

Apr 22, 2026

Company Details

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients an...

CEO

James H. Yamanaka

IPO Date

May 21, 2019

Website

www.organigram.ca

Key Metrics TTM

Revenue

$205M

+68.5% YoY

Net Income

$13M

EPS (Diluted)

$0.10

Free Cash Flow

-$27M

Revenue / Share

$1.50

Gross Margin

35.6%

Operating Margin

-4.3%

Net Margin

6.5%

FCF Margin

-13.0%

P/S

1.0x

P/E

14.9x

Earnings Reports

Q2 2026

May 11, 2026

PENDING

Q1 2026

Feb 10, 2026

$46M+48.6%EPS $0.11

Q4 2025

Dec 16, 2025

$59M+79.1%EPS -$0.20

Q3 2025

Aug 13, 2025

$52M+72.4%EPS -$0.03

Q2 2025

May 12, 2025

$48M+74.3%EPS $0.23

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 22	$23M	$7M	-$5M
Q3 22	$28M	$6M	-$9M
Q4 22	$33M	$10M	-$6M
Q1 23	$32M	$17M	$3M
Q2 23	$29M	$7M	-$8M
Q3 23	$24M	-$3M	-$161M
Q4 23	$34M	-$9M	-$29M
Q1 24	$27M	$5M	-$12M
Q2 24	$27M	-$663.5K	-$11M
Q3 24	$30M	$10M	-$4M
Q4 24	$33M	$13M	$206.8K
Q1 25	$31M	$10M	-$8M
Q2 25	$48M	$13M	-$6M
Q3 25	$52M	$19M	-$2M
Q4 25	$59M	$23M	$868.9K
Q1 26	$46M	$17M	-$2M

Valuation

Quarter	P/S	P/E
Q2 22	2.5x	—
Q3 22	2.2x	—
Q4 22	1.8x	—
Q1 23	1.7x	—
Q2 23	1.6x	—
Q3 23	1.7x	—
Q4 23	1.7x	—
Q1 24	1.7x	—
Q2 24	1.8x	—
Q3 24	1.7x	—
Q4 24	1.7x	—
Q1 25	1.6x	—
Q2 25	1.4x	16.0x
Q3 25	1.2x	34.7x
Q4 25	1.0x	—
Q1 26	1.0x	14.9x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 22	-$586.8K	-$7M
Q3 22	-$5M	-$17M
Q4 22	-$14M	-$26M
Q1 23	$3M	-$4M
Q2 23	-$14M	-$18M
Q3 23	-$4M	-$11M
Q4 23	-$12M	-$17M
Q1 24	$6M	$5M
Q2 24	-$6M	-$6M
Q3 24	-$3M	-$4M
Q4 24	$6M	$5M
Q1 25	-$3M	-$4M
Q2 25	-$12M	-$17M
Q3 25	$11M	$4M
Q4 25	-$691.6K	-$290.7K
Q1 26	-$12M	-$13M

Capital Expenditures

Quarter	CapEx
Q2 22	$6M
Q3 22	$13M
Q4 22	$12M
Q1 23	$6M
Q2 23	$4M
Q3 23	$7M
Q4 23	$5M
Q1 24	$1M
Q2 24	$325.2K
Q3 24	$777.6K
Q4 24	$1M
Q1 25	$1M
Q2 25	$5M
Q3 25	$7M
Q4 25	$400.9K
Q1 26	$2M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 22	+117.4%	-11.7%
Q3 22	+87.5%	+53.8%
Q4 22	+82.9%	+15.0%
Q1 23	+42.6%	-11.0%
Q2 23	+24.1%	+29.8%
Q3 23	-14.0%	+404.3%
Q4 23	+1.2%	+58.1%
Q1 24	-15.8%	+33.4%
Q2 24	-4.7%	+4.8%
Q3 24	+25.2%	-81.7%
Q4 24	-2.9%	-48.0%
Q1 25	+17.2%	+3.2%
Q2 25	+74.3%	+38.7%
Q3 25	+72.4%	+58.1%
Q4 25	+79.1%	+77.6%
Q1 26	+48.6%	+23.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 22	$640.9K	2.8%
Q3 22	$556.1K	2.0%
Q4 22	$2M	6.2%
Q1 23	$1M	4.3%
Q2 23	$980.7K	3.4%
Q3 23	$968.3K	4.0%
Q4 23	$0	0.0%
Q1 24	$1M	5.5%
Q2 24	$1M	5.3%
Q3 24	$2M	5.1%
Q4 24	$798.7K	2.4%
Q1 25	$968.3K	3.1%
Q2 25	$685.5K	1.4%
Q3 25	$735.9K	1.4%
Q4 25	$692.0K	1.2%
Q1 26	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q2 22	$865.2K	$7M	$2M	—
Q3 22	$1M	$9M	$3M	—
Q4 22	$2M	$9M	$3M	—
Q1 23	$2M	$8M	$3M	—
Q2 23	$2M	$8M	$3M	—
Q3 23	$3M	$10M	$3M	—
Q4 23	$3M	—	—	$17M
Q1 24	$3M	$9M	$3M	—
Q2 24	$2M	$11M	$4M	—
Q3 24	$2M	$8M	$4M	—
Q4 24	$1M	$7M	$3M	—
Q1 25	$2M	$8M	$4M	—
Q2 25	$2M	$11M	$5M	—
Q3 25	$2M	$11M	$6M	—
Q4 25	$2M	$12M	$7M	—
Q1 26	$2M	$10M	$7M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 22	$60M	$50M	$110M
Q3 22	$93M	$233.8K	$93M
Q4 22	$50M	$22M	$72M
Q1 23	$51M	$19M	$70M
Q2 23	$45M	$8M	$53M
Q3 23	$39M	$234.6K	$39M
Q4 23	$25M	$0	$25M
Q1 24	$31M	$376.4K	$31M
Q2 24	$52M	$586.1K	$53M
Q3 24	$58M	$979.2K	$59M
Q4 24	$78M	$600.0K	$79M
Q1 25	$32M	$2M	$34M
Q2 25	$10M	$638.0K	$10M
Q3 25	$26M	$657.7K	$27M
Q4 25	$21M	$603.6K	$21M
Q1 26	$45M	$587.8K	$46M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 22	85M	+4.6%	+46.7%
Q3 22	85M	0.0%	+18.6%
Q4 22	85M	0.0%	+14.0%
Q1 23	89M	+4.4%	+9.2%
Q2 23	78M	-11.9%	-8.0%
Q3 23	80M	+2.6%	-5.6%
Q4 23	81M	+0.8%	-4.9%
Q1 24	81M	0.0%	-8.9%
Q2 24	91M	+12.3%	+16.2%
Q3 24	108M	+18.9%	+34.7%
Q4 24	108M	0.0%	+33.5%
Q1 25	114M	+4.9%	+40.0%
Q2 25	134M	+17.5%	+46.5%
Q3 25	134M	+0.3%	+23.6%
Q4 25	134M	+0.2%	+23.8%
Q1 26	137M	+2.0%	+20.3%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 22	$12M	2
Q3 22	$14M	2
Q4 22	$17M	2
Q1 23	$16M	2
Q2 23	$14M	2
Q3 23	$12M	2
Q4 23	$17M	2
Q1 24	$13M	2
Q2 24	$14M	2
Q3 24	$15M	2
Q4 24	$16M	2
Q1 25	$16M	2
Q2 25	$24M	2
Q3 25	$26M	2
Q4 25	$29M	2
Q1 26	$23M	2

Revenue / Employee